Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
US8138336B2 · kind B2 · utility
1Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 22, 2008 |
| Grant date | Mar 20, 2012 |
| Priority date | — |
| Expiry date | Sep 22, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to novel compounds and processes for their preparation, methods of treating diseases, particularly Cancer, comprising administering said compounds, and methods of making pharmaceutical compositions for the treatment or prevention of disorders, particularly Cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.